ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HAO vs FCDH // EV/EBITDA & P/E VALUATION

Haoxi Health Technology Limited (Class A) (NASDAQ) VS. Forcendra Holding Limited (Class A) (NASDAQ) • 15-METRIC TALLY: HAO 3 — FCDH 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HAO VS. FCDH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HAO FCDH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 23.70% +72.30 HAO /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin 68.00% -60.00% +128.00 HAO /net-margins <GO>
Revenue Growth (YoY) -54.60% -8.80% -45.80 FCDH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 HAO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.0 42.1 -8.14 FCDH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.3M $3.1M -$1.8M FCDH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HAO REV FCDH REV HAO GROSS % FCDH GROSS % HAO FCF FCDH FCF
FY 2025 $537.6K $7.5M 98.0% 23.7% -$3.4M -$3.5M
FY 2024 $1.2M $8.2M 98.0% 20.5% -$802.9K -$1.5M
FY 2023 $28.2M $8.0M — — -$872.1K -$7.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HAO // BETA —
FCDH // BETA —